Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own ...

Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies ...

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for ...

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...

Novo Nordisk NVO has appealed to the U.S. Food and Drug Administration (FDA) to halt the production of compounded versions of ...

FDA recalls thousands of antidepressant bottles due to cancer-causing chemical{beacon} Health Care Health Care   The Big ...

The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...

There are a few. Ozempic and other semaglutide medications can come with uncomfortable side effects —like nausea, diarrhea, ...

The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.

In the middle is the FDA trying to referee the high-stakes and increasingly ... from manufacturing copycat versions of its ...

Many people use semaglutides like Ozempic for weight loss, but can you use it to lose a small amount—say, 10 or 20 pounds?

Ozempic microdosing is when patients lower the dosage of Ozempic or other injectable weight loss medications to take smaller ...